Bill Summary: HB 1503

• Establishes requirements for electronic transmission of prescriptions directly to pharmacies without intermediary access, including transmitter identification and transmission details

• Mandates electronic prescription devices use neutral platforms without advertising, messaging, or economic incentives designed to influence prescribing decisions at point of care

• Permits disclosure of insurance formulary information if all covered drugs and pharmacies are readily available to practitioners and electronic prior authorization is available for exceptions

• Authorizes the State Board of Pharmacy to promulgate rules governing the electronic prior authorization process

• Effective date: November 1, 2011